MedTrace Logo

Subanalysis in Patients With CARDIoLAMinopathy Enrolled to REPORT-CCM Registry

NCT04904393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-05-27

No results posted yet for this study

Summary

Observational, retrospective registry with acute and chronic endpoints

Conditions

Interventions

DEVICE

Implant of the device for Cardiac Contractility Modulation (CCM) Therapy

The intervention is an implant of CCM therapy devices and it is similar to conventional dual chamber cardiac devices with only difference of to insert n 2 leads fixed in right ventricular septum

Sponsors & Collaborators

  • Monaldi Hospital

    lead OTHER

Principal Investigators

  • Antonio D'Onofrio, MD · Ao dei Colli - Monaldi Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904393 on ClinicalTrials.gov